Literature DB >> 7857268

Increased expression of heparin binding epidermal growth-factor-like growth factor mRNA in the kidney of streptozotocin-induced diabetic rats.

Y J Lee1, S J Shin, S R Lin, M S Tan, J H Tsai.   

Abstract

Heparin binding epidermal growth factor (HB-EGF), a new member of the EGF family, is a potent mitogen for smooth muscle cells, fibroblasts, and mesangial cells. To study whether the HB-EGF is involved in the development of diabetic nephropathy, we measured the expression of the HB-EGF gene in the kidney tissues of streptozotocin-induced diabetic rats by Northern blot analysis. The mean kidney weight of diabetic rats without strict blood sugar control was significantly increased as compared to that of the control group. Renal HB-EGF mRNA expression was also increased in diabetic rats without strict blood sugar control at 7 days after induction of diabetes and remained elevated for the entire 3-month study period. Strict insulin treatment abolished the elevation of HB-EGF mRNA expression and kidney growth. As HB-EGF is a mitogen for mesangial cells, our results suggest that HB-EGF may be involved in the development of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7857268     DOI: 10.1006/bbrc.1995.1175

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Heparin-binding EGF-like growth factor is up-regulated in the obstructed kidney in a cell- and region-specific manner and acts to inhibit apoptosis.

Authors:  H T Nguyen; S H Bride; A B Badawy; R M Adam; J Lin; A Orsola; P D Guthrie; M R Freeman; C A Peters
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  High Glucose Up-regulates ADAM17 through HIF-1α in Mesangial Cells.

Authors:  Renzhong Li; Lalita Uttarwar; Bo Gao; Martine Charbonneau; Yixuan Shi; John S D Chan; Claire M Dubois; Joan C Krepinsky
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

3.  Heparin-binding EGF-like growth factor contributes to reduced glomerular filtration rate during glomerulonephritis in rats.

Authors:  L Feng; G E Garcia; Y Yang; Y Xia; F B Gabbai; O W Peterson; J A Abraham; R C Blantz; C B Wilson
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

Review 4.  Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy.

Authors:  Kathryn M Thrailkill; R Clay Bunn; John L Fowlkes
Journal:  Endocrine       Date:  2008-10-30       Impact factor: 3.633

5.  Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis.

Authors:  Guillaume Bollée; Martin Flamant; Sandra Schordan; Cécile Fligny; Elisabeth Rumpel; Marine Milon; Eric Schordan; Nathalie Sabaa; Sophie Vandermeersch; Ariane Galaup; Anita Rodenas; Ibrahim Casal; Susan W Sunnarborg; David J Salant; Jeffrey B Kopp; David W Threadgill; Susan E Quaggin; Jean-Claude Dussaule; Stéphane Germain; Laurent Mesnard; Karlhans Endlich; Claude Boucheix; Xavier Belenfant; Patrice Callard; Nicole Endlich; Pierre-Louis Tharaux
Journal:  Nat Med       Date:  2011-09-25       Impact factor: 53.440

Review 6.  Cellular crosstalk of glomerular endothelial cells and podocytes in diabetic kidney disease.

Authors:  Shan Jiang; Manyu Luo; Xue Bai; Ping Nie; Yuexin Zhu; Hangxi Cai; Bing Li; Ping Luo
Journal:  J Cell Commun Signal       Date:  2022-01-18       Impact factor: 5.908

7.  Erlotinib preserves renal function and prevents salt retention in doxorubicin treated nephrotic rats.

Authors:  Raed N Bou Matar; Janet D Klein; Jeff M Sands
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

Review 8.  Role of epidermal growth factor receptor in acute and chronic kidney injury.

Authors:  Jinhua Tang; Na Liu; Shougang Zhuang
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

9.  Case of Proteinuria, Worsening Hypertension, and Glomerular Endotheliosis With Erlotinib and Gefitinib.

Authors:  Sheron Latcha; Edgar A Jaimes; Victoria Gutgarts; Surya Seshan
Journal:  Kidney Int Rep       Date:  2018-07-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.